Skip to main content
. 2020 Nov 10;38(1):164–180. doi: 10.1111/pde.14408

Table 14.

Consensus statements: the impact of iPLEDGE

SORT

All patients and prescribers of isotretinoin in the United States must comply with current iPLEDGE guidelines.

I, A

The iPLEDGE program was not designed for long‐term use of isotretinoin in patients with ichthyosis and imposes a significant burden on this patient population.

III, C